Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc. (BGMSP): 7 pipeline candidates · ~43 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
43.4 months
D/E 0.12 · 0% dilution
Lead: Approved
7 candidates
N/A
N/A
A transparent, data-derived signal for Bio Green Med Solution, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$6.0M
Cash
$3.3M
Quarterly Burn
$278K
Runway
43.4 mo
Revenue
$778K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| afp/ob ria kit | Approved |
| bio rad monolisa anti-hbc igm eia | Approved |
| bio-rad cyclosporine by hplc test | Approved |
| bio-rad monolisa anti-hbs eia | Approved |
| coseal surgical sealant; coseal spray set | — |
| hp 13c pyruvate | Phase 2 |
| plogosertib (plogo) | Phase 1 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1
Total value held
$565
| Holder | Shares | Value |
|---|---|---|
| vsm wealth advisory, llc | 1,882 | $565 |
Frequently asked questions
How many drug candidates are in Bio Green Med Solution, Inc.'s pipeline?
Bio Green Med Solution, Inc. (BGMSP) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Bio Green Med Solution, Inc.'s lead drug candidate?
Bio Green Med Solution, Inc.'s most advanced tracked candidate is afp/ob ria kit (Approved) for Immunology.
What is Bio Green Med Solution, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Bio Green Med Solution, Inc. has approximately 43.4 months of cash runway.
What is Bio Green Med Solution, Inc.'s market capitalization?
Bio Green Med Solution, Inc.'s market capitalization is approximately $6.0M.
Who is the CEO of Bio Green Med Solution, Inc.?
Dr. Sing Ee Wong is the chief executive officer of Bio Green Med Solution, Inc. (BGMSP).
Get the full picture on Bio Green Med Solution, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.